Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cryoport, Inc.CYRX · Entity 5125 | Director | June 05, 2026 | June 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cryoport, Inc.
Report date June 05, 2026 · Filed June 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 91,108 |
Reported balance
After 2026-06-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-05 · Grant · Acquired 10,350 · Balance 91,108 F1: Reflects grant of restricted stock rights that vest in full on June 5, 2027, and upon vesting automatically convert to shares of common stock on a one-for-one basis. |
| Common StockSEC Table I · non-derivative | Direct | 67,894 |
Reported balance
After 2026-06-08 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-06-08 · Sale · Disposed 23,214 · Balance 67,894 F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.40 to $15.48, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Option (Right to Buy Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $15.70 · Expires 2033-06-05 | Direct | 16,077 |
Reported balance
After 2026-06-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-05 · Grant · Acquired 16,077 · Balance 16,077 F3: 1/12th of the options vest on the 5th of the month for twelve months beginning July 5, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects grant of restricted stock rights that vest in full on June 5, 2027, and upon vesting automatically convert to shares of common stock on a one-for-one basis.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.40 to $15.48, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: 1/12th of the options vest on the 5th of the month for twelve months beginning July 5, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 08, 2026 Filed Jun 9, 2026 01:05 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 23,214 | $15.44 | $358,452.02 |
DisclosureSEC source: 0001104659-26-071506 · tm2617191-1_4seq1.xml · nonDerivative · entry 2 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,894 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.40 to $15.48, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 01:05 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantOption (Right to Buy Common Stock) · Derivative | 16,077 | $0.00 Strike: $15.70 | $0.00 |
DisclosureSEC source: 0001104659-26-071506 · tm2617191-1_4seq1.xml · derivative · entry 3 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,077 Underlying: Common Stock · 16,077 shares Expires 2033-06-05 F3 · derivative.exercise_date: 1/12th of the options vest on the 5th of the month for twelve months beginning July 5, 2026. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 01:05 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 10,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-071506 · tm2617191-1_4seq1.xml · nonDerivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,108 F1 · security: Reflects grant of restricted stock rights that vest in full on June 5, 2027, and upon vesting automatically convert to shares of common stock on a one-for-one basis. F1 · price: Reflects grant of restricted stock rights that vest in full on June 5, 2027, and upon vesting automatically convert to shares of common stock on a one-for-one basis. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 22:30 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 11,570 | $9.99 | $115,540.33 |
DisclosureSEC source: 0001104659-25-120727 · tm2533338-1_4seq1.xml · nonDerivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,758 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.93 to $10.0696, inclusive. Read SEC document |
| July 22, 2025 Filed Jul 24, 2025 21:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $3.07 | $0.00 |
DisclosureSEC source: 0001104659-25-070419 · tm2521579-1_4seq1.xml · derivative · entry 3 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,000 shares Expires 2025-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on June 10, 2025. The proceeds of the sale of Common Stock were used to pay the exercise price and withholding taxes due upon exercise of the Stock Option reported in this Form 4. F3 · derivative.exercise_date: 1/48 of the options vested on the 19th of each month for forty-eight months beginning on 8/19/2015. Read SEC document |
| July 22, 2025 Filed Jul 24, 2025 21:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 40,728 | $7.24 | $294,899.23 |
DisclosureSEC source: 0001104659-25-070419 · tm2521579-1_4seq1.xml · nonDerivative · entry 2 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,328 F1 · shares: This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on June 10, 2025. The proceeds of the sale of Common Stock were used to pay the exercise price and withholding taxes due upon exercise of the Stock Option reported in this Form 4. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.75 to $7.49, inclusive. Read SEC document |
| July 22, 2025 Filed Jul 24, 2025 21:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 60,000 | $3.07 | $184,200.00 |
DisclosureSEC source: 0001104659-25-070419 · tm2521579-1_4seq1.xml · nonDerivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,056 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on June 10, 2025. The proceeds of the sale of Common Stock were used to pay the exercise price and withholding taxes due upon exercise of the Stock Option reported in this Form 4. Read SEC document |
| June 24, 2025 Filed Jun 27, 2025 00:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $3.07 | $0.00 |
DisclosureSEC source: 0001104659-25-063165 · tm2519235d1_4seq1.xml · derivative · entry 3 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 20,000 shares Expires 2025-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on June 10, 2025. F3 · derivative.exercise_date: 1/48 of the options vested on the 19th of each month for forty-eight months beginning on 8/19/2015. Read SEC document |
| June 24, 2025 Filed Jun 27, 2025 00:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 13,321 | $7.02 | $93,446.82 |
DisclosureSEC source: 0001104659-25-063165 · tm2519235d1_4seq1.xml · nonDerivative · entry 2 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,056 F1 · shares: This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on June 10, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.07, inclusive. Read SEC document |
| June 24, 2025 Filed Jun 27, 2025 00:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 20,000 | $3.07 | $61,400.00 |
DisclosureSEC source: 0001104659-25-063165 · tm2519235d1_4seq1.xml · nonDerivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,377 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on June 10, 2025. Read SEC document |
| June 13, 2025 Filed Jun 13, 2025 23:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 624 | $6.80 | $4,246.13 |
DisclosureSEC source: 0001104659-25-059506 · tm2517996-1_4seq1.xml · nonDerivative · entry 3 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,377 Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 23:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 1,895 | $7.01 | $13,286.41 |
DisclosureSEC source: 0001104659-25-059506 · tm2517996-1_4seq1.xml · nonDerivative · entry 2 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,001 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.03, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 23:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 8,193 | $7.06 | $57,815.54 |
DisclosureSEC source: 0001104659-25-059506 · tm2517996-1_4seq1.xml · nonDerivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,896 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.05, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 09, 2025 Filed Jun 10, 2025 23:25 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 5,622 | $7.06 | $39,672.77 |
DisclosureSEC source: 0001104659-25-058268 · tm2517578-3_4seq1.xml · nonDerivative · entry 2 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,089 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.13, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 06, 2025 Filed Jun 10, 2025 23:25 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantOption (Right to Buy Common Stock) · Derivative | 41,098 | $0.00 Strike: $7.00 | $0.00 |
DisclosureSEC source: 0001104659-25-058268 · tm2517578-3_4seq1.xml · derivative · entry 3 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,098 Underlying: Common Stock · 41,098 shares Expires 2032-06-06 F3 · derivative.exercise_date: 1/12th of the options vest on the 6th of the month for twelve months beginning July 6, 2025. Read SEC document |
| June 06, 2025 Filed Jun 10, 2025 23:25 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 23,214 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-058268 · tm2517578-3_4seq1.xml · nonDerivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,711 F1 · security: Reflects grant of restricted stock rights that vest in full on June 6, 2026, and upon vesting automatically convert to shares of common stock on a one-for-one basis. F1 · price: Reflects grant of restricted stock rights that vest in full on June 6, 2026, and upon vesting automatically convert to shares of common stock on a one-for-one basis. Read SEC document |
| December 02, 2024 Filed Dec 5, 2024 00:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionStock Option (right to buy) · Derivative | 10,834 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001104659-24-125631 · tm2430199-1_4seq1.xml · derivative · entry 3 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,834 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. The proceeds of the sale of Common Stock were used to pay the exercise price and withholding taxes due upon exercise of the Stock Option reported in this Form 4. F3 · derivative.exercise_date: The options vested ratably over forty-eight months on the 18th day of each month beginning on 1/18/2015. Read SEC document |
| December 02, 2024 Filed Dec 5, 2024 00:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 7,369 | $7.46 | $54,977.90 |
DisclosureSEC source: 0001104659-24-125631 · tm2430199-1_4seq1.xml · nonDerivative · entry 2 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,497 F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. The proceeds of the sale of Common Stock were used to pay the exercise price and withholding taxes due upon exercise of the Stock Option reported in this Form 4. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.10 to $7.81, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 02, 2024 Filed Dec 5, 2024 00:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 10,834 | $4.80 | $52,003.20 |
DisclosureSEC source: 0001104659-24-125631 · tm2430199-1_4seq1.xml · nonDerivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. The proceeds of the sale of Common Stock were used to pay the exercise price and withholding taxes due upon exercise of the Stock Option reported in this Form 4. Read SEC document |
| August 02, 2024 Filed Aug 7, 2024 00:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionStock Option (right to buy) · Derivative | 4,167 | $0.00 Strike: $5.04 | $0.00 |
DisclosureSEC source: 0001104659-24-086387 · tm2421024-1_4seq1.xml · derivative · entry 3 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,167 shares Expires 2024-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options vested ratably over twelve months on the 29th day of each month beginning on 9/29/14. Read SEC document |
| August 02, 2024 Filed Aug 7, 2024 00:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 4,167 | $8.04 | $33,520.18 |
DisclosureSEC source: 0001104659-24-086387 · tm2421024-1_4seq1.xml · nonDerivative · entry 2 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,032 F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.80 to $8.29, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 02, 2024 Filed Aug 7, 2024 00:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 4,167 | $5.04 | $21,001.68 |
DisclosureSEC source: 0001104659-24-086387 · tm2421024-1_4seq1.xml · nonDerivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. Read SEC document |
| May 17, 2024 Filed May 21, 2024 23:03 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantOption (Right to Buy Common Stock) · Derivative | 23,830 | $0.00 Strike: $12.65 | $0.00 |
DisclosureSEC source: 0001104659-24-063968 · tm2415098-5_4seq1.xml · derivative · entry 2 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,830 Underlying: Common Stock · 23,830 shares Expires 2031-05-17 F2 · derivative.exercise_date: 1/12th of the options vest on the 17th of the month for twelve months beginning June 17, 2024. Read SEC document |
| May 17, 2024 Filed May 21, 2024 23:03 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 12,845 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-063968 · tm2415098-5_4seq1.xml · nonDerivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,032 F1 · security: Reflects grant of restricted stock rights that vest in full on May 17, 2025, and upon vesting automatically convert to shares of common stock on a one-for-one basis. F1 · price: Reflects grant of restricted stock rights that vest in full on May 17, 2025, and upon vesting automatically convert to shares of common stock on a one-for-one basis. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 23:49 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionStock Option (right to buy) · Derivative | 8,334 | $0.00 Strike: $5.40 | $0.00 |
DisclosureSEC source: 0001104659-24-036283 · tm249281-3_4seq1.xml · derivative · entry 3 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,334 shares Expires 2024-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 23:49 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 3,217 | $14.68 | $47,225.56 |
DisclosureSEC source: 0001104659-24-036283 · tm249281-3_4seq1.xml · nonDerivative · entry 2 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,187 Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 23:49 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 8,334 | $5.40 | $45,003.60 |
DisclosureSEC source: 0001104659-24-036283 · tm249281-3_4seq1.xml · nonDerivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,404 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2023 Filed May 16, 2023 23:28 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantOption (Right to Buy Common Stock) · Derivative | 15,125 | $0.00 Strike: $20.05 | $0.00 |
DisclosureSEC source: 0001104659-23-061521 · tm2316016-4_4seq1.xml · derivative · entry 2 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,125 Underlying: Common Stock · 15,125 shares Expires 2030-05-12 F2 · derivative.exercise_date: 1/12th of the options vest on the 12th of the month for twelve months beginning June 12, 2023. Read SEC document |
| May 12, 2023 Filed May 16, 2023 23:28 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 8,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-061521 · tm2316016-4_4seq1.xml · nonDerivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,016 F1 · security: Reflects grant of restricted stock rights that vest in full on May 12, 2024, and upon vesting automatically convert to shares of common stock on a one-for-one basis. F1 · price: Reflects grant of restricted stock rights that vest in full on May 12, 2024, and upon vesting automatically convert to shares of common stock on a one-for-one basis. Read SEC document |
| April 30, 2022 Filed May 4, 2022 00:01 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionRestricted Stock Rights · Derivative | 2,708 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-055439 · tm2214402-4_4seq1.xml · derivative · entry 3 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,708 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date. F2 · derivative.expiration_date: Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date. Read SEC document |
| April 30, 2022 Filed May 4, 2022 00:01 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 2,708 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-055439 · tm2214402-4_4seq1.xml · nonDerivative · entry 2 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,911 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date. Read SEC document |
| April 29, 2022 Filed May 4, 2022 00:01 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantOption (Right to Buy Common Stock) · Derivative | 13,981 | $0.00 Strike: $22.56 | $0.00 |
DisclosureSEC source: 0001104659-22-055439 · tm2214402-4_4seq1.xml · derivative · entry 4 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,981 Underlying: Common Stock · 13,981 shares Expires 2029-04-29 F3 · derivative.exercise_date: 1/12th of the options vest on the 30th of the month for twelve months beginning May 30, 2022. Read SEC document |
| April 29, 2022 Filed May 4, 2022 00:01 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 7,203 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-055439 · tm2214402-4_4seq1.xml · nonDerivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,203 F1 · security: Reflects grant of restricted stock rights that vest in full on April 29, 2023, and upon vesting automatically convert to shares of common stock on a one-for-one basis. F1 · price: Reflects grant of restricted stock rights that vest in full on April 29, 2023, and upon vesting automatically convert to shares of common stock on a one-for-one basis. Read SEC document |
| April 30, 2021 Filed May 7, 2021 22:43 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantRestricted Stock Rights · Derivative | 2,708 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-063252 · tm2115610d5_4.xml · derivative · entry 2 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,708 Underlying: Common Stock · 2,708 shares Expires 2022-04-30 F2 · derivative.exercise_price: Each restricted stock right represents a contingent right to receive one share of CYRX common stock. Read SEC document |
| April 30, 2021 Filed May 7, 2021 22:43 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantOption to purchase common stock · Derivative | 5,416 | $0.00 Strike: $56.57 | $0.00 |
DisclosureSEC source: 0001104659-21-063252 · tm2115610d5_4.xml · derivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,416 Underlying: Common Stock · 5,416 shares Expires 2028-04-30 F1 · derivative.exercise_date: 1/12th of options vest on the 30th of the month for twelve months beginning May 30, 2021. Read SEC document |
| November 24, 2020 Filed Nov 25, 2020 20:35 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 11,092 | $48.00 | $532,416.00 |
DisclosureSEC source: 0001104659-20-129467 · tm2037162-1_4.xml · nonDerivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,054 Read SEC document |
| May 01, 2020 Filed May 6, 2020 01:10 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantOptions to purchase common stock · Derivative | 35,000 | $0.00 Strike: $18.02 | $0.00 |
DisclosureSEC source: 0001104659-20-057098 · tm2018763d3_4.xml · derivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2030-05-01 F1 · derivative.exercise_date: 1/12 of these options vest and become exercisable on the 1st of each month for twelve (12) months beginning on 06/01/2020. Read SEC document |
| May 02, 2019 Filed May 3, 2019 23:51 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantOptions to purchase common stock · Derivative | 35,000 | $0.00 Strike: $14.35 | $0.00 |
DisclosureSEC source: 0001144204-19-023716 · tv520660_4.xml · derivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2029-05-02 F1 · derivative.exercise_date: 1/12 of these options vested and became exercisable in equal monthly installments on the 2nd of each month for the next twelve (12) months beginning on 05/02/2019. Read SEC document |
| March 31, 2019 Filed Apr 2, 2019 23:19 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 628 | $13.27 | $8,333.56 |
DisclosureSEC source: 0001144204-19-017850 · tv517947_4.xml · nonDerivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,146 Read SEC document |
| December 31, 2018 Filed Jan 4, 2019 00:34 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 832 | $10.02 | $8,336.64 |
DisclosureSEC source: 0001144204-19-000509 · tv510319_4.xml · nonDerivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,518 Read SEC document |
| September 30, 2018 Filed Oct 2, 2018 22:21 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 660 | $12.63 | $8,335.80 |
DisclosureSEC source: 0001144204-18-052132 · tv504087_4.xml · nonDerivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,686 Read SEC document |
| June 30, 2018 Filed Jul 3, 2018 20:28 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 551 | $15.12 | $8,331.12 |
DisclosureSEC source: 0001144204-18-037242 · tv497994_4.xml · nonDerivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,026 Read SEC document |
| May 17, 2018 Filed May 22, 2018 01:01 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantOptions to purchase common stock · Derivative | 35,000 | $0.00 Strike: $9.29 | $0.00 |
DisclosureSEC source: 0001144204-18-030146 · tv494663_4.xml · derivative · entry 2 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2028-05-17 F2 · derivative.exercise_date: 1/12 of these options vest and become exercisable in equal monthly installments on the 17th of each month for the next twelve (12) months beginning on 06/17/2018. Options issued under the compensation plan for non-employee directors for services as director during the 2018/19 term. Read SEC document |
| March 31, 2018 Filed Apr 2, 2018 18:27 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 923 | $9.03 | $8,334.69 |
DisclosureSEC source: 0001144204-18-018533 · tv490139_4.xml · nonDerivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,475 Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 21:33 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 951 | $8.76 | $8,330.76 |
DisclosureSEC source: 0001144204-18-000539 · tv482502_4.xml · nonDerivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,552 Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 10:05 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 839 | $9.93 | $8,331.27 |
DisclosureSEC source: 0001144204-17-051048 · v476324_4.xml · nonDerivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,601 Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 23:46 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 1,762 | $4.73 | $8,334.26 |
DisclosureSEC source: 0001144204-17-035800 · v470254_4.xml · nonDerivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,762 Read SEC document |
| June 23, 2017 Filed May 22, 2018 01:01 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantOptions to purchase common stock · Derivative | 35,000 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001144204-18-030146 · tv494663_4.xml · derivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2027-06-23 F1 · derivative.exercise_date: 1/12 of these options vested and became exercisable in equal monthly installments on the 23rd of each month for the next twelve (12) months beginning on 07/23/2017. Options issued under the compensation plan for non-employee directors for services as director during the 2017/18 term. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 15:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 4,006 | $2.08 | $8,332.48 |
DisclosureSEC source: 0001144204-17-018753 · v463377_4.xml · nonDerivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 22:45 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 2,502 | $3.33 | $8,331.66 |
DisclosureSEC source: 0001144204-17-000646 · v456151_4.xml · nonDerivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,994 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.